$233 Billion is the total value of ORBIMED CAPITAL LLC's 29 reported holdings in Q4 2002. The portfolio turnover from Q3 2002 to Q4 2002 was - .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
No holdings reported for quarter Q4 2002 |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2003-02-14
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
CYBIN INC. | February 14, 2023 | 6,153,299 | 3.7% |
Milestone Pharmaceuticals Inc.Sold out | February 14, 2023 | 0 | 0.0% |
Aptose Biosciences Inc.Sold out | February 11, 2022 | 0 | 0.0% |
SI-BONE, Inc. | February 11, 2022 | 2,305,300 | 6.9% |
Foamix Pharmaceuticals Ltd. | February 14, 2020 | 2,577,982 | 4.2% |
CRYOCOR INC | June 19, 2007 | 389,432 | 3.2% |
DOV PHARMACEUTICAL INCSold out | August 15, 2006 | 0 | 0.0% |
GIVEN IMAGING LTD | August 14, 2006 | 3,637,255 | 13.3% |
ORPHAN MEDICAL INC | May 06, 2005 | 1,080,000 | 9.4% |
TANOX INC | October 14, 2004 | 3,851,300 | 8.8% |
View ORBIMED CAPITAL LLC's complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
4 | 2024-04-05 |
13F-NT | 2024-02-14 |
144 | 2023-12-11 |
13F-NT | 2023-11-14 |
144 | 2023-10-02 |
4 | 2023-08-31 |
144 | 2023-08-30 |
144 | 2023-08-21 |
144 | 2023-08-15 |
13F-NT | 2023-08-14 |
View ORBIMED CAPITAL LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.